However, a recent study, also conducted in mutant SOD1 (G93A) mice, revealed that the effects of CB2 receptor agonists in experimental ALS could depend on the stage of the disease, being detrimental in presymptomatic mice but changing to beneficial in later stages [32]. Here, SOD1 is linked to amyotrophic lateral sclerosis.